Program Player Image

System Hardware/Software and Internet Connection Requirements:

The following information is provided for your reference in conjunction with review of this program.
General System and Internet Requirements:  Speakers or Headphones, High Speed Internet connection, Web browsers: Internet Explorer, Firefox, Safari and Google Chrome.
Flash Icon Image
Adobe Flash Player Browser Plugin:
Version 9.0 or higher:  For Free download Click Here.
Operating Systems:  Windows 2000 or higher, MAC OSX 10.3 or higher.
When ready select the "View Online Program" button to begin.
To return to this page select the back button in your browser.
Note: Program can take 30 to 60 seconds to load, please be patient.


Estimated time for completion: 1.5 hours
Date of release: April 1, 2012
Expiration date: March 31, 2013
Format: Self Instructional - Audio Visual
Jointly Sponsored by: AKH Inc., The CHEST Foundation, Not One More Life, Inc., and CME-University.
Commercially Supported: This activity is provided through an educational grant from Teva Pharmaceuticals Pharmaceuticals.

Despite 3 iterations of the NAEPP Guidelines for the Diagnosis and Management of Asthma, disparities in the prevalence, morbidity and mortality of asthma remain alarmingly persistent among certain populations. Healthcare providers must be aware of these disparities in the populations they serve. Moreover, providers must understand current insights into potential causes of these disparities and the related implications for effective provider, patient and community based education and management to reduce and ultimately eliminate these disparities.



This activity is designed for primary care practitioners who care for patients with asthma.



There are no fees to participate and receive credit for this activity.



Upon completion of the educational activity, participants should be able to:

  • Review and discuss the recent trends in asthma epidemiology with respect to minorities, children, women and the poor
  • Discuss the potential role of culture and ethnicity in disparities attributable to asthma
  • Discuss racial and ethnic disparities in the use of asthma medications and patterns of health care utilization
  • Appreciate and apply successful strategies for effective community based programs to address asthma disparities


Steven B. Deitelzweig, MD, FACP

LeRoy M. Graham, MD, FCCP

Georgia Pediatric Pulmonology Associates, PC
Associate Clinical Professor of Pediatrics
Morehouse School of Medicine
Founder and Medical Director Not One More Life, Inc

LeRoy M. Graham, Jr., MD, FCCP is Associate Clinical Professor of Pediatrics at Morehouse School of Medicine and Staff Physician at Scottish Rite Children’s Medical Center, Hughes Spalding Children’s Hospital, and Egleston Children’s Hospital, all located in Atlanta, Georgia. He is also one of the partners of Georgia Pediatric Pulmonology Associates, PC, a private practice in Atlanta, Georgia. He is also founder and Medical Director of Not One More Life Asthma, Inc. He received his medical degree from Georgetown University School of Medicine in Washington, DC. Dr. Graham completed his internship and residency in pediatrics at Fitzsimons Army Medical Center in Aurora, Colorado, and he completed a fellowship in pediatric pulmonology at the University of Colorado Health Sciences Center in Denver, Colorado. In addition, he completed a fellowship in pulmonary research at the Cardiovascular Pulmonary Research Laboratory of the Webb Waring Lung Institute in Denver. Dr. Graham serves on the Board of Regents of the American College of Chest Physicians (ACCP) and on the AACP’s Diversity Task Force commissioned to address health disparities attributable to respiratory disease; he also serves as chair of the Task Force’s subcommittee on education and research.

Dr. Graham has published numerous articles and abstracts in Chest, Journal of the Society of Plastic and Reconstructive Surgery, American Review of Respiratory Disease, Pediatrics and Journal of the American Medical Association.

Dr. Graham may be reached at



LeRoy M. Graham, MD, FCCP

SPEAKER AND ADVISER: Merck & Company, Inc.
SPEAKER AND ADVISER: Teva Pharmaceuticals
CONTRACT RESEARCH GRANT: Novartis Pharmaceuticals



It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may bementioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity. AKH, CME University, The CHEST Foundation, and Not One More Life, Inc. planners and reviewers, outside of those listed, have no relevant financial relationships to disclose.



This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


AKH Logo


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc., CME University Inc., The CHEST Foundation, and Not One More Life, Inc. AKH is accredited by the ACCME to provide continuing medical education for physicians.

AKH designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.



To receive continuing education credit, participants should review all written materials, complete and submit a post-test and evaluation, and score at least 70% on the post-test. A statement of credit will be available for printing upon successful completion. If you have questions about this CME/CE activity, please contact AKH Inc. at



Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.



To view our privacy policy click the link provided.